Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas

Journal of Neuro-Oncology

Volumn 88, Issue 2, 2008, Pages 143-155

  Sakuma, Takahiro ^a   Nakagawa, Takao ^a   Ido, Kazunori ^a   Takeuchi, Hiroaki ^a   Sato, Kazufumi ^a   Kubota, Toshihiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Edema; HuR; Hypoxia; Meningioma; VEGF A

Indexed keywords

HUR PROTEIN; MESSENGER RNA; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN EDEMA; BRAIN TUMOR; CANCER CELL CULTURE; CANCER GRADING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MENINGIOMA; PREOPERATIVE CARE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGRAPHY; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD34; ANTIGENS, SURFACE; BRAIN EDEMA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, UNSATURATED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; OXYGEN; RNA, MESSENGER; RNA-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43149126092     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9559-8     Document Type: Article

References (43)

1. Samoto K, Ikezaki K, Ono M et al (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189-1193
2. Kalkanis SN, Carroll RS, Zhang J et al (1996) Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85:1095-1101
3. Goldman CK, Bharara S, Palmer CA et al (1997) Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40:1269-1277
4. Provias J, Claffey K, delAguila L et al (1997) Meningiomas: Role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016-1026
5. Bitzer M, Opitz H, Popp J et al (1998) Angiogenesis and brain oedema in intracranial meningiomas: Influence of vascular endothelial growth factor. Acta Neurochir (Wien) 140:333-340
6. Yoshioka H, Hama S, Taniguchi E et al (1999) Peritumoral brain edema associated with meningioma: Influence of vascular endothelial growth factor expression and vascular blood supply. Cancer 85:936-944
7. Paek SH, Kim CY, Kim YY et al (2002) Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol 60:235-245
8. Pistolesi S, Fontanini G, Camacci T et al (2002) Meningioma-associated brain oedema: The role of angiogenic factors and pial blood supply. J Neurooncol 60:159-164
9. Pistolesi S, Fontanini G, Boldrini L et al (2003) The role of somatostatin in vasogenic meningioma associated brain edema. Tumori 89:136-140
10. Otsuka S, Tamiya T, Ono Y et al (2004) The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 70:349-357
11. Pistolesi S, Boldrini L, Gisfredi S et al (2004) Angiogenesis in intracranial meningiomas: Immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118-125
12. Pietsch T, Valter MM, Wolf HK et al (1997) Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol (Berl) 93:109-117
13. Lamszus K, Lengler U, Schmidt NO et al (2000) Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 46:938-947
14. Denizot Y, De Armas R, Caire F et al (2006) The quantitative analysis of bFGF and VEGF by ELISA in human meningiomas. Mediators Inflamm 2006:36376
15. Bitzer M, Wöckel L, Luft AR et al (1997) The importance of pial blood supply to the development of peritumoral brain edema in meningiomas. J Neurosurg 87:368-373
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO Classification of tumours of the central nervous system. IARC Press, Lyon
17. Kawano H, Hayashi M, Kabuto M et al (1988) An immunohistochemical and ultrastructural study of cultured intracranial hemangiopericytoma. Clin Neuropathol 7:105-110
18. Kubota T, Hayashi M, Hasegawa M et al (1990) Extracellular matrix protein synthesis from cultured human meningioma cells. Brain Tumor Pathol 7:7-16
19. Ueda Y, Nakagawa T, Kubota T et al (2005) Glioma cells under hypoxic conditions block the brain microvascular endothelial cell death induced by serum starvation. J Neurochem 95:99-110
20. Erkinheimo TL, Lassus H, Sivula A et al (2003) Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 63:7591-7594
21. Donnini S, Machein MR, Plate KH et al (1999) Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. J Pathol 189:66-71
22. Park K, Kim JH, Nam DH et al (2000) Vascular endothelial growth factor expression under ischemic stress in human meningiomas. Neurosci Lett 283:45-48
23. Yamasaki F, Yoshioka H, Hama S et al (2000) Recurrence of meningiomas. Cancer 89:1102-1110
24. Jensen RL, Soleau S, Bhayani MK et al (2002) Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 97:658-667
25. Kiliç T, Bayri Y, Ozduman K et al (2002) Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 51:183-192
26. Lewy-Trenda I, Omulecka A, Janczukowicz J et al (2003) The morphological analysis of vasculature and angiogenic potential in meningiomas: immunoexpression of CD31 and VEGF antibodies. Folia Neuropathol 41:149-153
27. Boldrini L, Pistolesi S, Gisfredi S et al (2006) Expression of endothelin 1 and its angiogenic role in meningiomas. Virchows Arch 449:546-553
28. Maiuri F, De Caro Mdel B, Esposito F et al (2007) Recurrences of meningiomas: Predictive value of pathological features and hormonal and growth factors. J Neurooncol 82:63-68
29. Tamiya T, Ono Y, Matsumoto K et al (2001) Peritumoral brain edema in intracranial meningiomas: Effects of radiological and histological factors. Neurosurgery 49:1046-1051
30. Nakano T, Asano K, Miura H et al (2002) Meningiomas with brain edema: radiological characteristics on MRI and review of the literature. Clin Imaging 26:243-249
31. Takeguchi T, Miki H, Shimizu T et al (2003) Prediction of tumor-brain adhesion in intracranial meningiomas by MR imaging and DSA. Magn Reson Med Sci 2:171-179
32. Gurkanlar D, Er U, Sanli M et al (2005) Peritumoral brain edema in intracranial meningiomas. J Clin Neurosci 12:750-753
33. Bitzer M, Wöckel L, Morgalla M et al (1997) Peritumoural brain oedema in intracranial meningiomas: Influence of tumour size, location and histology. Acta Neurochir (Wien) 139:1136-1142
34. Mattei TA, Mattei JA, Ramina R et al (2005) Edema and malignancy in meningiomas. Clinics 60:201-206
35. Yoo H, Baia GS, Smith JS et al (2007) Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13:68-75
36. Levy AP, Levy NS, Goldberg MA (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271:2746-2753
37. López de Silanes I, Lal A, Gorospe M (2005) HuR: post-transcriptional paths to malignancy. RNA Biol 2:11-13
38. Yoo PS, Mulkeen AL, Cha CH (2006) Post-transcriptional regulation of vascular endothelial growth factor: Implications for tumor angiogenesis. World J Gastroenterol 12:4937-4942
39. Nabors LB, Gillespie GY, Harkins L et al (2001) HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61:2154-2161
40. Denkert C, Weichert W, Pest S et al (2004) Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 64:189-195
41. Heinonen M, Bono P, Narko K et al (2005) Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65:2157-2161
42. Mrena J, Wiksten JP, Thiel A et al (2005) Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res 11:7362-7368
43. Cho NP, Han HS, Soh Y et al (2007) Overexpression of cyclooxygenase-2 correlates with cytoplasmic HuR expression in salivary mucoepidermoid carcinoma but not in pleomorphic adenoma. J Oral Pathol Med 36:297-303